Use of Blood Coagulation Factor XIII for Treating Hemophilia A
AssigneeZymoGenetics, Inc.
InventorsJan Ohrstrom, Paul D. Bishop, Lynn Massman Rose
Life of this patent
Estimating the term…
Abstract
A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.
Claims5
A method for treating hemophilia A comprising administering recombinant Factor XIII to an individual having hemophilia A.
A method for treating hemophilia A comprising administering recombinant Factor XIII in conjunction with Factor VIII to an individual having hemophilia A.
A method for treating hemophilia A comprising administering recombinant Factor XIII in conjunction with desmopressin to an individual having hemophilia A.
A method for treating hemophilia A comprising administering recombinant Factor XIII in conjunction with desmopressin and factor VIII to an individual having hemophilia A.
Dependencies are inferred from the claim text.